Stocks
Turn Therapeutics Inc.TTRX
NASDAQHealthcareBiotechnology$10.28
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing topical therapies for dermatologic conditions, including a lead candidate for treating fungal infections of the nail. Its proprietary delivery platform aims to improve drug penetration and patient outcomes. Investors track the company for its pipeline progress and potential in the specialty dermatology market.
52W Range: $2.57-$16.45
Congressional Interest in Turn Therapeutics Inc. (TTRX)
No congressional trades have been disclosed for Turn Therapeutics Inc. (TTRX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading TTRX?
No congressional trades found for this stock.